Sharing Alzheimer's Research Data with the World

The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease. ADNI researchers collect, validate and utilize data such as MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors for the disease. Data from the North American ADNI’s study participants, including Alzheimer’s disease patients, mild cognitive impairment subjects and elderly controls, are available from this site.

Welcome

Returning Users

News

New Biomarkers Consortium CSF Proteomics with Multiple Reaction Monitoring Data Now Available
New Biomarkers Consortium data is now available in the ADNI Data Archive. The dataset is...
Updated CSF Alpha-synuclein biospecimen data now available
Updated CSF Alpha-synuclein biospecimen data for ADNI1 subjects are now available in the ADNI...
RSS Feed More News >